Literature DB >> 34815954

Association between CDK8 gene polymorphisms and dilated cardiomyopathy in a Chinese Han population.

Ran Zhang1, Yue Zhong1, Si-Yu Long2, Qin-Ni Yang2, Bin Zhou3, Li Rao1.   

Abstract

BACKGROUND: Dilated cardiomyopathy (DCM) is one of the most common types of cardiomyopathies. Various genes have been verified to be related to DCM, but the pathogenesis remains unclear. Cyclin-dependent-kinase 8 (CDK8), encoded by the CDK8 gene, is a transcriptional factor that regulates the phosphorylation of RNA polymerase II. It plays an important role in the transcription process and different signaling pathways. This study aimed to investigate the potential role of CDK8 gene polymorphisms in DCM susceptibility and prognosis in a Chinese Han population.
METHODS: Two single nucleotide polymorphisms (SNPs) of CDK8, rs17083838 (A/G) and rs7992670 (A/G), were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 341 DCM patients and 381 healthy controls. Survival analysis was performed using Kaplan-Meier curves and Cox regression analysis.
RESULTS: The frequencies of allele A of both SNPs rs17083838 and rs7992670 were increased in DCM patients compared to healthy controls (P<0.05). Genotypic frequencies of rs17083838 and rs7992670 were associated with the susceptibility to DCM in the codominant, and recessive models (P<0.05), and AA/AG genotypes of rs17083838 were also related to DCM susceptibility in the dominant model. AA/AG genotypes of rs17083838 and the AA genotype of rs7992670 in the dominant and recessive genetic models presented a correlation with the poor prognosis of DCM patients in both univariate (P<0.05) and multivariate analyses (P<0.05) after adjusting for age, gender, left ventricular end-diastolic diameter (LVEDD), and left ventricular ejection fraction (LVEF).
CONCLUSIONS: This research is the first to reveal that CDK8 gene polymorphisms might be related to DCM susceptibility and prognosis in the Chinese Han population. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  CDK8; Dilated cardiomyopathy (DCM); polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP); single nucleotide polymorphism (SNP); survival analysis

Year:  2021        PMID: 34815954      PMCID: PMC8569267          DOI: 10.21037/cdt-21-323

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  38 in total

1.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

2.  A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn).

Authors:  Zhiqiang Li; Zhao Zhang; Zangdong He; Wei Tang; Tao Li; Zhen Zeng; Lin He; Yongyong Shi
Journal:  Cell Res       Date:  2009-04       Impact factor: 25.617

Review 3.  Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathies.

Authors:  Michael M Givertz; Douglas L Mann
Journal:  Curr Heart Fail Rep       Date:  2013-12

4.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

5.  CDK8 Kinase Activity Promotes Glycolysis.

Authors:  Matthew D Galbraith; Zdenek Andrysik; Ahwan Pandey; Maria Hoh; Elizabeth A Bonner; Amanda A Hill; Kelly D Sullivan; Joaquín M Espinosa
Journal:  Cell Rep       Date:  2017-11-07       Impact factor: 9.423

6.  CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.

Authors:  Ron Firestein; Adam J Bass; So Young Kim; Ian F Dunn; Serena J Silver; Isil Guney; Ellen Freed; Azra H Ligon; Natalie Vena; Shuji Ogino; Milan G Chheda; Pablo Tamayo; Stephen Finn; Yashaswi Shrestha; Jesse S Boehm; Supriya Jain; Emeric Bojarski; Craig Mermel; Jordi Barretina; Jennifer A Chan; Jose Baselga; Josep Tabernero; David E Root; Charles S Fuchs; Massimo Loda; Ramesh A Shivdasani; Matthew Meyerson; William C Hahn
Journal:  Nature       Date:  2008-09-14       Impact factor: 49.962

7.  Pathogenesis of CDK8-associated disorder: two patients with novel CDK8 variants and in vitro and in vivo functional analyses of the variants.

Authors:  Tomoko Uehara; Kota Abe; Masayuki Oginuma; Shizuka Ishitani; Hiroshi Yoshihashi; Nobuhiko Okamoto; Toshiki Takenouchi; Kenjiro Kosaki; Tohru Ishitani
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

8.  Mediator kinase inhibition further activates super-enhancer-associated genes in AML.

Authors:  Henry E Pelish; Brian B Liau; Ioana I Nitulescu; Anupong Tangpeerachaikul; Zachary C Poss; Diogo H Da Silva; Brittany T Caruso; Alexander Arefolov; Olugbeminiyi Fadeyi; Amanda L Christie; Karrie Du; Deepti Banka; Elisabeth V Schneider; Anja Jestel; Ge Zou; Chong Si; Christopher C Ebmeier; Roderick T Bronson; Andrei V Krivtsov; Andrew G Myers; Nancy E Kohl; Andrew L Kung; Scott A Armstrong; Madeleine E Lemieux; Dylan J Taatjes; Matthew D Shair
Journal:  Nature       Date:  2015-09-28       Impact factor: 49.962

9.  Kin28 regulates the transient association of Mediator with core promoters.

Authors:  Célia Jeronimo; François Robert
Journal:  Nat Struct Mol Biol       Date:  2014-04-06       Impact factor: 15.369

10.  A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease.

Authors:  Trevor Dale; Paul A Clarke; Christina Esdar; Dennis Waalboer; Olajumoke Adeniji-Popoola; Maria-Jesus Ortiz-Ruiz; Aurélie Mallinger; Rahul S Samant; Paul Czodrowski; Djordje Musil; Daniel Schwarz; Klaus Schneider; Mark Stubbs; Ken Ewan; Elizabeth Fraser; Robert TePoele; Will Court; Gary Box; Melanie Valenti; Alexis de Haven Brandon; Sharon Gowan; Felix Rohdich; Florence Raynaud; Richard Schneider; Oliver Poeschke; Andree Blaukat; Paul Workman; Kai Schiemann; Suzanne A Eccles; Dirk Wienke; Julian Blagg
Journal:  Nat Chem Biol       Date:  2015-10-26       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.